Pacific Edge serves up harsh dessert for shareholders
The vexed issue of shareholder compensation for continuous disclosure violations has reared its head again, prompting plenty of discussion in the market.
The vexed issue of shareholder compensation for continuous disclosure violations has reared its head again, prompting plenty of discussion in the market.
The latest case, involving Dunedin-based biotech company Pacific Edge [NZX: PEB], will have sent a jolt through the market, with many listed
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Shoeshine
Fri, 29 May 2015
Fri, 29 May 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Pacific Edge serves up harsh dessert for shareholders
Shoeshine,
48165